Table 4 Overview of treatment strategies that were changed by the multidisciplinary team
Movement disorder | Treatment category | Treatment specifics | N | Positive effect (n) |
|---|---|---|---|---|
Dystonia | ||||
Pharmacological | ||||
Clonazepam | 1 | 1 | ||
Gabapentin | 3 | 3 | ||
L-dopa | 2 | 1 | ||
Trihexyphenidyl | 8 | 3 | ||
Cessation of drug | 1 | 1 | ||
Botulinum toxin | 5 | 5 | ||
Deep brain stimulation | 5 | 4 | ||
Paramedical | 2 | 2 | ||
Total dystonia | 27 | 20 | ||
Myoclonus | ||||
Pharmacological | Clonazepam | 10 | 10 | |
Ketogenic diet | 4 | 1 | ||
Paramedical | 4 | 2 | ||
Total myoclonus | 18 | 12 | ||
Other | ||||
Pharmacological | ||||
L-dopa | 4 | 4 | ||
Acetozolamide | 1 | 1 | ||
Cessation of drug | 4 | 2 | ||
Botulinum toxin | 1 | 1 | ||
Paramedical | 3 | 2 | ||
Total other | 13 | 10 | ||
Difficult to classify | 2 | |||
Pharmacological | L-dopa | 2 | 1 | |
Total | 60 | 43 | ||